Abstract | PURPOSE:
Nuclear factor kappa B (NF-κB), a transcriptional factor that has been shown to be constitutively active in cervical cancer, is part of an important pathway leading to treatment resistance in many tumor types. The purpose of our study was to determine whether expression of NF-κB in pretreatment specimens and specimens taken shortly after treatment initiation correlated with outcome in cervical cancer patients treated with definitive chemoradiation. METHODS AND MATERIALS: Eighteen patients with locally advanced cervical cancer were enrolled in a study in which cervical biopsy specimens were obtained before radiation therapy and 48 h after treatment initiation. Matched biopsy specimens from 16 of these patients were available and evaluated for the nuclear expression of NF-κB protein by immunohistochemical staining. RESULTS: After a median follow-up of 43 months, there were 9 total treatment failures. Nuclear staining for NF-κB was positive in 3 of 16 pretreatment biopsy specimens (19%) and 5 of 16 postradiation biopsy specimens (31%). Pretreatment expression of NF-κB nuclear staining correlated with increased rates of local-regional failure (100% vs. 23%, p = 0.01), distant failure (100% vs. 38%, p = 0.055), disease-specific mortality (100% vs. 31%, p = 0.03), and overall mortality (100% vs. 38%, p = 0.055). CONCLUSIONS: Our data suggest that pretreatment nuclear expression of NF-κB may be associated with a poor outcome for cervical cancer patients treated with chemoradiation. Although these data require validation in a larger group of patients, the results support the continued study of the relationship between NF-κB and outcome in patients treated for carcinoma of the cervix.
|
Authors | Amit K Garg, Anuja Jhingran, Ann H Klopp, Bharat B Aggarwal, Ajai B Kunnumakkara, Russell R Broadus, Patricia J Eifel, Thomas A Buchholz |
Journal | International journal of radiation oncology, biology, physics
(Int J Radiat Oncol Biol Phys)
Vol. 78
Issue 5
Pg. 1331-6
(Dec 01 2010)
ISSN: 1879-355X [Electronic] United States |
PMID | 20231067
(Publication Type: Journal Article)
|
Copyright | Copyright © 2010 Elsevier Inc. All rights reserved. |
Chemical References |
- NF-kappa B
- Neoplasm Proteins
|
Topics |
- Adult
- Aged
- Biopsy
- Carcinoma, Squamous Cell
(drug therapy, metabolism, pathology, radiotherapy)
- Cervix Uteri
(metabolism, pathology)
- Female
- Follow-Up Studies
- Humans
- Middle Aged
- NF-kappa B
(metabolism)
- Neoplasm Proteins
(metabolism)
- Pilot Projects
- Prognosis
- Prospective Studies
- Uterine Cervical Neoplasms
(drug therapy, metabolism, pathology, radiotherapy)
|